ARCHIVES

In Brief: FDA To Review Preclinical Testing, Phase I Protocols At Open Advisory Group Meeting

This article is from The Cancer Letter archive.

Vol. 01 No. 46 | November 14, 1975

Download PDF Visit The Full Archive

Related Articles

Study Tests PARP Inhibitor ABT-888 For Several Cancers

September 25, 2009

ASCO Hit On Two Sides; AACR Split Criticized

June 26, 1992

National Cancer Policy Board will end in 2005, NCI to support a cancer forum at IOM.

November 5, 2004

NCI Oks Expanded Breast Cancer Low Fat Prevention Trial, Plans To End Stage 2 Adjuvant Low Fat Study

January 31, 1986

Treanda Approved For B-Cell Non-Hodgkin’s Lymphoma

October 31, 2008

Cancer Groups Propose Six Characteristics Of Next FDA Head.

December 19, 2008